Evidence map›Paper›PMID 34908964›Full record

ArticleClinical neuropsychiatry2020

Topiramate-Induced Acute Psychotic Symptoms: A Case Report.

Hamed Jafarpour, Alireza Razavi, Kamal Alaedini, Maryam Sefidgarnia, Davood Hosseini Talari

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical neuropsychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hamed JafarpourMedical Student, Student Research Committee, Addiction Institute and Department of Psychiatry, Mazandaran University of Medical Sciences, Sari, Iran.
Alireza RazaviMedical Student, Student Research Committee, Addiction Institute and Department of Psychiatry, Mazandaran University of Medical Sciences, Sari, Iran.
Kamal AlaediniPsychiatry and Behavioral Sciences Research Centre, Addiction Institute and Department of Psychiatry, Mazandaran University of Medical Sciences, Sari, Iran.
Maryam SefidgarniaPsychiatry and Behavioral Sciences Research Centre, Addiction Institute and Department of Psychiatry, Mazandaran University of Medical Sciences, Sari, Iran.
Davood Hosseini TalariAssistant Professor of Psychosomatic Medicine, Department of Psychiatry, School of Medicine, Rouhani Hospital Babol University of Medical Sciences, Babol, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 36-year-old man, married, nurse, presented with feeling fear and injury from imaginary creatures to a psychiatric clinic in Sari, Iran. Symptoms began two days before admission when tablet Topiramate was started due to the increasing intensity of chronic headache. About one hour after the first dose, Symptoms became apparent and resolved when he woke up. There was no hallucination and loss of consciousness. Next day, following use the same dose, the symptoms appeared. Eventually, Topiramate was discontinued and the patient did not experience similar symptoms in follow up.

Indexed as

MigrainePsychosisTopiramate

Identifiers

PMID34908964
PMCPMC8629074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.